Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Redx Pharma
Life Sciences
Strategy launch
By
Dr Martin Hall
02 Oct 2018
Palace Capital
Property
Initiation of coverage
By
Mike Foster
28 Sep 2018
Stay up-to-date with the latest research
Sign up to our newsletter
Allergy Therapeutics plc
Life Sciences
2018 full-year results: solid growth
By
Dr Martin Hall
27 Sep 2018
Haydale Graphene Industries Plc
Industrial
Exuberance, reality; enlightenment now to follow
By
Paul Singer
26 Sep 2018
Oxford BioMedica
Life Sciences
Partnering strategy delivering profitability
20 Sep 2018
City of London Investment Group
Financials
Strengthening cash position to boost returns
By
Dr Brian Moretta
20 Sep 2018
DP Poland Plc
Consumer
Initiation: Fully proven model rolls out
By
Jason Streets
18 Sep 2018
BigDish Ventures Ltd
Technology
Growth set to gather pace
By
Yingheng Chen
18 Sep 2018
Tissue Regenix
Life Sciences
Strategy delivering growth above expectations
By
Dr Martin Hall
14 Sep 2018
1pm Plc
Financials
Group synergies coming through
By
Mark Thomas
12 Sep 2018
Redx Pharma
Life Sciences
Back to the clinic
06 Sep 2018
Prev
1
...
56
57
58
59
60
...
75
Next